Aptent tincidunt lobortis eveniet! Molestie accusamus qui magna, consequatur posuere, sociosqu phasellus, nam sit dis fuga nemo eu, per duis vestibulum eveniet exercitationem assumenda, totam.
The most significant development occurs during the 1st trimester as the fertilized egg implants in the uterus, the baby’s organs begin to form and the embryo becomes a fetus. Morning sickness, fatigue, and frequent urination are common symptoms during the first trimester of pregnancy. The risk of miscarriage is highest during this trimester.
This trimester is also referred to as the golden trimester and is marked by a visible baby bump. Morning sickness tends to reduce during this period. The fetus grows rapidly during this trimester and movements of the fetus may be felt by the mother. Routine prenatal checkups and ultrasounds are scheduled to monitor the baby's development.
The baby gains weight and develops vital organs. The mother may experience increased discomfort due to the baby's size and increased pressure.
It’s important to book a checkup with your doctor. You should be prepared to talk about your family medical history and that of your partner, as well as your medical history, medications you’re currently taking and your lifestyle. This can help your doctor assess which tests may be needed.
A double marker test is a screening test that is used to assess the risk of certain chromosomal abnormalities and birth defects in a developing fetus. The test is typically performed during the first trimester of pregnancy, and it measures the levels of two specific proteins in the mother’s blood: Beta human chorionic gonadotropin hormone (Beta-hCG) and pregnancy- associated plasma protein – A (PAPP-A). The levels of hCG and PAPP- A can be used to estimate the risk of certain chromosomal abnormalities such as Down Syndrome, Edward syndrome and Patau syndrome.
This test, which includes PAPP-A, free Beta hCG, PlGF and AFP is the first biochemistry- only screening protocol for Down syndrome in the first trimester with 95% detection rate along with ultrasound scan
A triple marker test is a screening test that is used to assess the risk of certain chromosomal abnormalities and birth defects in a developing fetus. The test is typically performed during the second trimester of pregnancy and it measures the level of three specific substances in the mother’s blood: alpha-feto protein (AFP) + Beta hCG + Unconjugated Estriol (UE3). The level of AFP, hCG and UE3 can be used to estimate the risk of chromosomal abnormalities.